As of 2025-12-25, the Relative Valuation of BetterLife Pharma Inc (BETR.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 CAD, the upside of BetterLife Pharma Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-12-18 | -9.04 |
| 2025-12-17 | -9.04 |
| 2025-12-16 | -9.04 |
| 2025-12-15 | -9.04 |
| 2025-12-12 | -9.04 |
| 2025-12-11 | -10.85 |
| 2025-12-10 | -9.94 |
| 2025-12-09 | -11.75 |
| 2025-12-08 | -10.85 |
| 2025-12-05 | -9.94 |
| 2025-12-04 | -11.75 |
| 2025-12-02 | -11.75 |
| 2025-11-26 | -9.94 |
| 2025-11-25 | -10.85 |
| 2025-11-24 | -9.94 |
| 2025-11-21 | -9.04 |
| 2025-11-20 | -9.04 |
| 2025-11-17 | -10.85 |
| 2025-11-14 | -10.85 |
| 2025-11-13 | -10.85 |
| 2025-11-12 | -12.65 |
| 2025-11-10 | -10.85 |
| 2025-11-06 | -10.85 |
| 2025-11-05 | -11.75 |
| 2025-11-04 | -12.65 |
| 2025-11-03 | -10.85 |
| 2025-10-31 | -11.75 |
| 2025-10-30 | -10.85 |
| 2025-10-28 | -11.75 |
| 2025-10-27 | -11.75 |
| 2025-10-24 | -10.85 |
| 2025-10-23 | -10.85 |
| 2025-10-22 | -10.85 |
| 2025-10-21 | -10.85 |
| 2025-10-20 | -11.75 |
| 2025-10-17 | -11.75 |
| 2025-10-16 | -10.85 |
| 2025-10-15 | -10.85 |
| 2025-10-14 | -11.75 |
| 2025-10-10 | -11.75 |
| 2025-10-09 | -12.65 |
| 2025-10-07 | -12.65 |
| 2025-10-06 | -10.85 |
| 2025-10-03 | -12.65 |
| 2025-10-02 | -13.56 |
| 2025-10-01 | -12.65 |
| 2025-09-30 | -12.65 |
| 2025-09-29 | -13.56 |
| 2025-09-26 | -13.56 |
| 2025-09-25 | -13.56 |